6.3.2 Glucocorticoid therapy
Deflazacort
Deflazacort 6mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Duchenne muscular dystrophy |
Dexamethasone
Dexamethasone (base) 3.3mg/1ml solution for injection ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
| Malignant disease and immunosuppression | Chemotherapy induced nausea and vomiting |
Dexamethasone (base) 3.8mg/1ml solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
| Malignant disease and immunosuppression | Chemotherapy induced nausea and vomiting |
Dexamethasone (base) 6.6mg/2ml solution for injection ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Malignant disease and immunosuppression | Chemotherapy induced nausea and vomiting |
Dexamethasone (base) 6.6mg/2ml solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Malignant disease and immunosuppression | Chemotherapy induced nausea and vomiting |
Dexamethasone 2mg soluble tablets sugar free
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Malignant disease and immunosuppression | Chemotherapy induced nausea and vomiting |
Dexamethasone 2mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
| Malignant disease and immunosuppression | Chemotherapy induced nausea and vomiting |
Dexamethasone 2mg/5ml oral solution sugar free
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
Dexamethasone 4mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
Dexamethasone 500microgram tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
| Malignant disease and immunosuppression | Chemotherapy induced nausea and vomiting |
Hydrocortisone
Alkindi 0.5mg granules in capsules for opening
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Primary adrenal insufficiency (Addison’s disease) |
Alkindi 1mg granules in capsules for opening
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Primary adrenal insufficiency (Addison’s disease) |
Alkindi 2mg granules in capsules for opening
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Primary adrenal insufficiency (Addison’s disease) |
Alkindi 5mg granules in capsules for opening
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Primary adrenal insufficiency (Addison’s disease) |
Hydrocortisone 10mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Primary adrenal insufficiency (Addison’s disease) |
| Endocrine system | Corticosteroids – general use |
Hydrocortisone 2.5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Primary adrenal insufficiency (Addison’s disease) |
| Endocrine system | Corticosteroids – general use |
Hydrocortisone 20mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Primary adrenal insufficiency (Addison’s disease) |
| Endocrine system | Corticosteroids – general use |
Hydrocortisone sodium phosphate 100mg/1ml solution for injection ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Primary adrenal insufficiency (Addison’s disease) |
Methylprednisolone
Methylprednisolone 100mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Multiple sclerosis |
| Endocrine system | Corticosteroids – general use |
Methylprednisolone 16mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
Methylprednisolone 2mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
Methylprednisolone 4mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
Methylprednisolone acetate
Depo-Medrone 120mg/3ml suspension for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
Depo-Medrone 40mg/1ml suspension for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
Depo-Medrone 80mg/2ml suspension for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
Methylprednisolone sodium succinate
Methylprednisolone sodium succinate 125mg powder and solvent for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Skin | Autoimmune bullous dermatoses |
Methylprednisolone sodium succinate 1g powder and solvent for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Multiple sclerosis |
| Endocrine system | Corticosteroids – general use |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Skin | Autoimmune bullous dermatoses |
Methylprednisolone sodium succinate 40mg powder and solvent for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Skin | Autoimmune bullous dermatoses |
Methylprednisolone sodium succinate 500mg powder and solvent for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Multiple sclerosis |
| Endocrine system | Corticosteroids – general use |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Skin | Autoimmune bullous dermatoses |
Prednisolone
Prednisolone 10mg/ml oral solution sugar free
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Primary adrenal insufficiency (Addison’s disease) |
| Endocrine system | Corticosteroids – general use |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Prednisolone 1mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Primary adrenal insufficiency (Addison’s disease) |
| Endocrine system | Corticosteroids – general use |
Prednisolone 20mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
Prednisolone 25mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Corticosteroids – general use |
Prednisolone 5mg soluble tablets sugar free
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Duchenne muscular dystrophy |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Prednisolone 5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Primary adrenal insufficiency (Addison’s disease) |
| Endocrine system | Corticosteroids – general use |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Respiratory system | Chronic Obstructive Pulmonary Disease (COPD) |
| Skin | Autoimmune bullous dermatoses |